Menstrual cycle phase, menopausal transition stage, self-reports of premenstrual syndrome and symptom severity: observations from the Seattle Midlife Women's Health Study

Dysphoric mood, neuromuscular symptoms, and somatic symptoms exhibit cyclicity and are influenced by current premenstrual syndrome, but not vasomotor or insomnia symptoms. Late reproductive stage and early menopausal transition stages do not have significant effects on the five symptom groups. Abstract Objective The aim of this study was to determine the effects of menstrual cycle phases (postmenses and premenses), self-report of premenstrual syndrome (PMS), late reproductive stages (LRS1 and LRS2), and early menopausal transition (EMT) stage (Stages of Reproductive Aging Workshop [STRAW]) on severity of five symptom groups. Methods A subset of Seattle Midlife Women's Health Study participants (n = 290) in either LRS1 or LRS2 or EMT (STRAW+10 criteria) provided daily symptom data for at least one full menstrual cycle during the first year of the study and reported current PMS. Symptom severity was rated (1-4, least to most severe) in the daily diary for five symptom groups (dysphoric mood, neuromuscular, somatic, vasomotor, and insomnia) identified earlier with the same sample (Maturitas 1996;25:1-10). A three-way analysis of variance was used to test for within- and between-participants effects on symptom severity. Results Stage had no effect on severity for any of the five symptom groups. Dysphoric mood and neuromuscular and somatic symptom severity (but not vasomotor or insomnia severity) differed significantly across menstrual cycle phases, increasing from postmenses to premenses. Current PMS and premenses cycle phase had significant interactive effects on dysphoric mood and neuromuscular symptoms, but there were no significant interaction effects on somatic, vasomotor, or insomnia symptom severity. Conclusions Dysphoric mood, neuromuscular, and somatic symptoms exhibit cyclicity and are influenced by current PMS. Late reproductive stages and EMT stage do not have significant effects on the five symptom groups. Vasomotor or insomnia symptoms do not exhibit significant cyclicity from postmenses to premenses and are not affected by current PMS. Future studies of symptom cyclicity and reproductive aging including daily symptom data across an entire menstrual cycle in samples including women in late menopausal transition stage are essential to capture the effects of both cyclicity and self-reported PMS to capture symptom severity reports at their peak.

[1]  N. Woods,et al.  Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey , 2021, Menopause.

[2]  N. Woods,et al.  Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging. , 2021, Menopause.

[3]  S. Crawford,et al.  Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. , 2019, The Journal of clinical endocrinology and metabolism.

[4]  M. Lentz,et al.  Recognizing PMS When You See It: Criteria for PMS Sample Selection , 2019, Menstruation, Health, and Illness.

[5]  J. Bromberger,et al.  It is not just menopause: symptom clustering in the Study of Women’s Health Across the Nation , 2017, Women's Midlife Health.

[6]  K. Matthews,et al.  Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women’s Health Across the Nation , 2017, The Journal of clinical endocrinology and metabolism.

[7]  N. Woods,et al.  The Seattle Midlife Women’s Health Study: a longitudinal prospective study of women during the menopausal transition and early postmenopause , 2016, Women's Midlife Health.

[8]  R. Lipton,et al.  Sex hormones in women with and without migraine , 2016, Neurology.

[9]  D. Rubinow,et al.  Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition , 2016, Menopause.

[10]  S. Harlow,et al.  Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle. , 2014, Human reproduction.

[11]  A. Dobson,et al.  Using longitudinal profiles to characterize women’s symptoms through midlife: results from a large prospective study , 2012, Menopause.

[12]  P. Sluss,et al.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. , 2012, The Journal of clinical endocrinology and metabolism.

[13]  L. Dennerstein,et al.  Global study of women's experiences of premenstrual symptoms and their effects on daily life , 2011, Menopause international.

[14]  J. Legler,et al.  Core symptoms that discriminate premenstrual syndrome. , 2011, Journal of women's health.

[15]  N. Woods,et al.  Pain symptoms during the menopausal transition and early postmenopause , 2010, Climacteric : the journal of the International Menopause Society.

[16]  S. Crawford,et al.  Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. , 2009, Fertility and sterility.

[17]  H. Burger,et al.  Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition , 2009, Menopause.

[18]  Philippe Lehert,et al.  New findings from non-linear longitudinal modelling of menopausal hormone changes. , 2007, Human reproduction update.

[19]  H. Burger,et al.  Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. , 2007, The Journal of clinical endocrinology and metabolism.

[20]  Ellen W Freeman,et al.  Symptoms Associated With Menopausal Transition and Reproductive Hormones in Midlife Women , 2007, Obstetrics and gynecology.

[21]  S. Crawford,et al.  Recommendations from a multi-study evaluation of proposed criteria for Staging Reproductive Aging , 2007, Climacteric : the journal of the International Menopause Society.

[22]  M. Sammel,et al.  Associations of hormones and menopausal status with depressed mood in women with no history of depression. , 2006, Archives of general psychiatry.

[23]  I. Janssen,et al.  Relationship of day-to-day reproductive hormone levels to sleep in midlife women. , 2005, Archives of internal medicine.

[24]  M. Sammel,et al.  Premenstrual Syndrome as a Predictor of Menopausal Symptoms , 2004, Obstetrics and gynecology.

[25]  M. Soules,et al.  Executive summary: Stages of Reproductive Aging Workshop (STRAW). , 2001, Fertility and sterility.

[26]  M. Soules,et al.  Executive summary: Stages of Reproductive Aging Workshop (STRAW) , 2001, Climacteric : the journal of the International Menopause Society.

[27]  N. Woods,et al.  Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition , 2000, Menopause.

[28]  H. Burger,et al.  Mood and the menopausal transition , 1999 .

[29]  M. Lentz,et al.  Premenstrual symptoms: delineating symptom clusters. , 1999, Journal of women's health & gender-based medicine.

[30]  M. Heitkemper,et al.  Perceived stress, physiologic stress arousal, and premenstrual symptoms: group differences and intra-individual patterns. , 1998, Research in nursing & health.

[31]  E. Dudley,et al.  Mood and the menopausal transition. , 1998, The Journal of nervous and mental disease.

[32]  M. Heitkemper,et al.  Luteal phase ovarian steroids, stress arousal, premenses perceived stress, and premenstrual symptoms. , 1998, Research in nursing & health.

[33]  M. Heitkemper,et al.  PMS after 40: persistence of a stress-related symptom pattern. , 1997, Research in nursing & health.

[34]  N. Woods,et al.  Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. , 1996, Maturitas.

[35]  K. Rickels,et al.  Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms , 1995, Psychological Medicine.

[36]  J. Prior,et al.  The endocrinology of perimenopause: need for a paradigm shift. , 2011, Frontiers in bioscience.

[37]  M. Sammel,et al.  Hormones and menopausal status as predictors of depression in women in transition to menopause. , 2004, Archives of general psychiatry.

[38]  J. Grisso,et al.  Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. , 2001, Journal of women's health & gender-based medicine.

[39]  Andy P. Field,et al.  Discovering Statistics Using SPSS , 2000 .